Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofer Merimsky

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Medicine|October 20, 2004
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observationOfer Merimsky
Oncology Letters|February 20, 2013
The evolution in melanoma treatment as a reflection of precision-oriented medicineIgal Kushnir, Ofer Merimsky
Molecular and Clinical Oncology|September 15, 2018
Efficacy and safety of Nivolumab in non-small cell lung cancer patients in Tel-Aviv tertiary medical center: Facing the realitySivan Shamai, Ofer Merimsky
The Israel Medical Association Journal : IMAJ|June 4, 2002
Bone metastases of renal cell carcinoma: the role of surgeryJacob Bickels, Ofer Merimsky
The Israel Medical Association Journal : IMAJ|October 17, 2018
Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life PerspectiveSivan Shamai, Ofer Merimsky
Frontiers in Oncology|July 12, 2017
Soft-Tissue Sarcoma following Traumatic Injury: Case Report and Review of the LiteratureYael Bar, Ofer Merimsky
Expert Review of Anticancer Therapy|March 12, 2014
Optimal management of sarcomas of the breast: an updateEran Nizri, Ofer Merimsky, Guy Lahat
The Israel Medical Association Journal : IMAJ|February 13, 2018
A Case Report of Metastatic Primary Thyroid Leiomyosarcoma Treated with PazopanibIgal Kushnir, Viacheslav Soyfer, Ofer Merimsky
International Journal of Oncology|June 6, 2007
Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma modelOfer Merimsky, Yaara Gorzalczany, Ronit Sagi-Eisenberg
Translational Oncology|September 8, 2019
Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent MechanismYaara Gorzalczany, Ofer Merimsky, Ronit Sagi-Eisenberg
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Medicine|October 20, 2004
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observationOfer Merimsky
Oncology Letters|February 20, 2013
The evolution in melanoma treatment as a reflection of precision-oriented medicineIgal Kushnir, Ofer Merimsky
Molecular and Clinical Oncology|September 15, 2018
Efficacy and safety of Nivolumab in non-small cell lung cancer patients in Tel-Aviv tertiary medical center: Facing the realitySivan Shamai, Ofer Merimsky
The Israel Medical Association Journal : IMAJ|June 4, 2002
Bone metastases of renal cell carcinoma: the role of surgeryJacob Bickels, Ofer Merimsky
The Israel Medical Association Journal : IMAJ|October 17, 2018
Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life PerspectiveSivan Shamai, Ofer Merimsky
Frontiers in Oncology|July 12, 2017
Soft-Tissue Sarcoma following Traumatic Injury: Case Report and Review of the LiteratureYael Bar, Ofer Merimsky
Expert Review of Anticancer Therapy|March 12, 2014
Optimal management of sarcomas of the breast: an updateEran Nizri, Ofer Merimsky, Guy Lahat
The Israel Medical Association Journal : IMAJ|February 13, 2018
A Case Report of Metastatic Primary Thyroid Leiomyosarcoma Treated with PazopanibIgal Kushnir, Viacheslav Soyfer, Ofer Merimsky
International Journal of Oncology|June 6, 2007
Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma modelOfer Merimsky, Yaara Gorzalczany, Ronit Sagi-Eisenberg
Translational Oncology|September 8, 2019
Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent MechanismYaara Gorzalczany, Ofer Merimsky, Ronit Sagi-Eisenberg
Pageof 8